DE60021369D1 - Verfahren zur abschätzung eines magengeschwür-risikos - Google Patents

Verfahren zur abschätzung eines magengeschwür-risikos

Info

Publication number
DE60021369D1
DE60021369D1 DE60021369T DE60021369T DE60021369D1 DE 60021369 D1 DE60021369 D1 DE 60021369D1 DE 60021369 T DE60021369 T DE 60021369T DE 60021369 T DE60021369 T DE 60021369T DE 60021369 D1 DE60021369 D1 DE 60021369D1
Authority
DE
Germany
Prior art keywords
phenotype
gastritis
risk
evaluation
pepsinogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60021369T
Other languages
English (en)
Other versions
DE60021369T2 (de
Inventor
Pentti Sipponen
Matti Haerkoenen
Osmo Suovaniemi
Erik Forsblom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biohit Oy
Original Assignee
Biohit Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oy filed Critical Biohit Oy
Publication of DE60021369D1 publication Critical patent/DE60021369D1/de
Application granted granted Critical
Publication of DE60021369T2 publication Critical patent/DE60021369T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/595—Gastrins; Cholecystokinins [CCK]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/062—Gastritis or peptic ulcer disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Seal Device For Vehicle (AREA)
DE60021369T 1999-04-30 2000-04-28 Verfahren zur Abschätzung eines Magengeschwürrisikos Expired - Lifetime DE60021369T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI990992 1999-04-30
FI990992A FI118653B (fi) 1999-04-30 1999-04-30 Menetelmä peptisen haavan riskin määrittämiseksi
PCT/FI2000/000377 WO2000067035A1 (en) 1999-04-30 2000-04-28 Method for assessing the risk of peptic ulcer, comprising the steps of determining quantitatively the concentrations of pepsinogen i (pgi) and gastrin-17 in a serum sample

Publications (2)

Publication Number Publication Date
DE60021369D1 true DE60021369D1 (de) 2005-08-25
DE60021369T2 DE60021369T2 (de) 2006-05-24

Family

ID=8554567

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60021369T Expired - Lifetime DE60021369T2 (de) 1999-04-30 2000-04-28 Verfahren zur Abschätzung eines Magengeschwürrisikos

Country Status (13)

Country Link
US (1) US6872543B1 (de)
EP (1) EP1173770B1 (de)
JP (1) JP4598959B2 (de)
CN (1) CN100573152C (de)
AT (1) ATE300053T1 (de)
AU (1) AU4299800A (de)
DE (1) DE60021369T2 (de)
DK (1) DK1173770T3 (de)
ES (1) ES2241597T3 (de)
FI (1) FI118653B (de)
PT (1) PT1173770E (de)
RU (1) RU2225615C2 (de)
WO (1) WO2000067035A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
JP2005508838A (ja) * 2001-03-23 2005-04-07 アフトン コーポレーション 膵癌の組合せ治療
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
KR20040049830A (ko) * 2001-07-09 2004-06-12 애프톤 코포레이션 간, 폐 및 식도의 암 및 전암 상태의 치료 및 예방
SE0200974D0 (sv) * 2002-03-27 2002-03-27 Phagen Ab Screening method for gastritis
FI119571B (fi) * 2002-09-06 2008-12-31 Biohit Oyj Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
US7235376B2 (en) * 2003-03-28 2007-06-26 Receptor Biologix, Inc. Gastrin hormone immunoassays
FI119572B (fi) * 2004-03-05 2008-12-31 Biohit Oyj Menetelmä vatsan limakalvon tilan ennustamiseksi
JP5576592B2 (ja) * 2004-03-29 2014-08-20 キャンサー アドヴァンシズ インコーポレイテッド ガストリンホルモンに対するモノクローナル抗体
EP1794586B1 (de) 2004-09-22 2013-01-30 Cancer Advances, Inc., Monoklonale antikörper gegen progastrin
US8272265B2 (en) * 2005-07-12 2012-09-25 Technion Research And Development Foundation Ltd. System and method for active detection of asymmetry in rotating structures
EP2203745A4 (de) * 2007-10-26 2010-12-08 Biohit Oyj Verfahren und produkte zur diagnostizierung von autoimmunerkrankungen und magenkarzinom in assoziation mit atropher gastritis
RU2465597C1 (ru) * 2011-04-08 2012-10-27 Сергей Михайлович Котелевец Способ определения вероятности развития рака желудка
RU2582565C1 (ru) * 2015-03-06 2016-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Оренбургский государственный медицинский университет" Министерства здравоохранения Российской Федерации /ГБОУ ВПО ОрГМУ Минздрава России/ Способ дифференциальной диагностики язвы желудка и двенадцатиперстной кишки
CN104820096B (zh) * 2015-04-30 2017-04-19 必欧瀚生物技术（合肥）有限公司 一种判断早期胃癌风险检测用标志物的量的联合标准量及在筛查早期胃癌方面的应用
CN107328938A (zh) * 2016-09-23 2017-11-07 清华大学深圳研究生院 胃蛋白酶原和抗幽门螺杆菌抗体检测方法及其试剂盒
CN107271669A (zh) * 2016-09-23 2017-10-20 清华大学深圳研究生院 胃蛋白酶原、抗幽门螺杆菌抗体和胃泌素17检测方法及其试剂盒
JP6885581B2 (ja) * 2017-02-06 2021-06-16 学校法人東京歯科大学 ガストリン測定におけるカットオフ値の推定方法
JP7469225B2 (ja) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク． 腫瘍及び癌に対する体液性及び細胞性免疫を誘発するための組成物及び方法
RU2677228C1 (ru) * 2017-12-08 2019-01-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" Способ иммунодиагностики заболеваний гастродуоденальной зоны

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07304800A (ja) * 1994-05-06 1995-11-21 Nippon Igaku Rinshiyou Kensa Kenkyusho:Kk ヒトペプシノゲンに対するモノクローナル抗体
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
JP2949474B2 (ja) * 1995-08-28 1999-09-13 隆久 古田 ペプシノーゲンｉ／ｉｉ比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法
JPH10148636A (ja) * 1996-11-15 1998-06-02 Takahisa Furuta ペプシノーゲン ｉ／ｉｉ 比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法

Also Published As

Publication number Publication date
CN1355888A (zh) 2002-06-26
US6872543B1 (en) 2005-03-29
EP1173770A1 (de) 2002-01-23
WO2000067035A1 (en) 2000-11-09
AU4299800A (en) 2000-11-17
EP1173770B1 (de) 2005-07-20
CN100573152C (zh) 2009-12-23
DE60021369T2 (de) 2006-05-24
FI118653B (fi) 2008-01-31
JP4598959B2 (ja) 2010-12-15
FI990992A (fi) 2000-10-31
ATE300053T1 (de) 2005-08-15
ES2241597T3 (es) 2005-11-01
JP2002543433A (ja) 2002-12-17
RU2225615C2 (ru) 2004-03-10
FI990992A0 (fi) 1999-04-30
DK1173770T3 (da) 2005-08-08
PT1173770E (pt) 2005-09-30

Similar Documents

Publication Publication Date Title
DE60021369D1 (de) Verfahren zur abschätzung eines magengeschwür-risikos
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
ATE520979T1 (de) Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
ATE330223T1 (de) Verfahren zur quantitativen hämoglobinbestimmung in unverdünntem nichthämolysiertem vollblut
WO2002040998A3 (de) Kit und verfahren zur multianalytbestimmung
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
ATE378404T1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
WO2005094332A3 (en) Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators in non-small cell lung cancer
DE60228557D1 (de) Candida-nachweis
ATE232559T1 (de) Verfahren zur signalverstärkung
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
DK1513878T3 (da) Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE479101T1 (de) Verfahren zur quantifizierung von denaturiertem lipoprotein
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen
ATE382861T1 (de) Universeller biosensor und verfahren zur verwendung
ATE469241T1 (de) Verfahren zur vorbehandlung von proben zur bestimmung von verzuckerten aminen, sowie verfahren zur bestimmung von verzuckerten aminen
DE60324698D1 (de) Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum
ATE421093T1 (de) Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten
ATE339683T1 (de) Verfahren zur detektion und konzentrationsbestimmung von schwefelfreien odoriermitteln in erd- oder brenngas
ATE482283T1 (de) Verfahren, biosensoren und kits zum nachweis und zur identifizierung von pilzen
WO2003027656A3 (en) Electrochemical control of the redox environment for the analysis of a sample
FI990991A0 (fi) Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition